7 results match your criteria: "Centre Hospitalier Sud Ile de France[Affiliation]"

Article Synopsis
  • The study investigates whether high-flow nasal oxygen (HFNO) alone can reduce 28-day mortality in immunocompromised patients with acute respiratory failure compared to a combination of HFNO and non-invasive ventilation (NIV).
  • The FLORALI-IM trial includes adults in 29 ICUs, utilizing random assignment to either HFNO alone or alternating between NIV and HFNO, with strict exclusion criteria for certain severe conditions.
  • The goal is to evaluate the effectiveness of HFNO alone as a potentially safer alternative to NIV for patients with serious respiratory issues.
View Article and Find Full Text PDF

Patients identified as allergic to β-lactams are frequently exposed to treatment with broad-spectrum antibiotics. However, the risk of carriage of extended-spectrum β-lactamase (ESBL)-producing isolates in this population has been poorly investigated. The aim of this study was to evaluate the characteristics and clinical outcomes of patients admitted to the intensive care unit (ICU) with and without declared β-lactam allergy at admission.

View Article and Find Full Text PDF

Introduction: Non-invasive ventilation (NIV) is recommended as first-line therapy in respiratory failure of critically ill immunocompromised patients as it can decrease intubation and mortality rates as compared with standard oxygen. However, its recommendation is only conditional. Indeed, the use of NIV in this setting has been challenged recently based on results of trials finding similar outcomes with or without NIV or even deleterious effects of NIV.

View Article and Find Full Text PDF

To evaluate the effectiveness of trimetoprim-sulfametoxazole (TMP-SMX) for treatment of ventilator-associated pneumonia (VAP). A retrospective cohort study including patients with VAP from 2011 to 2017. Two groups were analysed: TMP-SMX group, including patients who had received TMP-SMX (as first-line and as de-escalation), and No-TMP-SMX group, including patients who had not received TMP-SMX treatment.

View Article and Find Full Text PDF

Autoimmune myelofibrosis is a distinct clinicopathological entity that occurs with autoimmune disorders. We report the case of a 44-year-old woman admitted with pancytopenia and clinical features of systemic lupus erythematosus, Sjogren's syndrome and antiphospholipid antibodies syndrome. Bone marrow biopsy showed decreased global cells and an increase of reticulin fibres on argentic coloration, consistent with myelofibrosis.

View Article and Find Full Text PDF

This study aimed to assess whether post-prescription review and feedback (PPRF) of all antibiotics, with restriction of carbapenems, fluoroquinolones and third-generation cephalosporins (3GCs), along with a change in medical standard of care impacted antibiotic consumption and bacterial antimicrobial resistance in a French medical/surgical intensive care unit (ICU). A 4-year before (2007-2010) and after (2011-2014) retrospective comparative study was performed. Antibiotic consumption was evaluated in defined daily doses per 1000 patient-days.

View Article and Find Full Text PDF
Article Synopsis
  • In 2017, five cases of severe hemorrhages linked to cefazolin treatment were noted in France, prompting a study to evaluate bleeding risks associated with the drug.
  • Researchers performed a retrospective study analyzing 132 patients treated with cefazolin, with 59 patients having available coagulation parameters for a more detailed examination.
  • While a significant increase in activated partial thromboplastin time (aPTT) was observed during treatment, there was no correlation between this increase and the occurrence of severe hemorrhages, indicating that bleeding might be more common than previously reported.
View Article and Find Full Text PDF